WebMar 31, 2024 · The Bacterial Vaginosis -Drugs In Development research report provides a comprehensive overview on the therapeutics under development for Bacterial Vaginosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. WebOct 27, 2000 · This study will explore new screening methods for early detection of breast and ovarian cancer in women at high risk for these diseases, because they have an altered breast cancer 1 (BRCA1) or breast cancer 2 (BRCA2) gene.
National Center for Biotechnology Information
WebFeb 18, 2024 · LABthera-001 in Bacterial Vaginosis Drug Details: LABthera-001 is under development for the treatment of bacterial vaginosis. The drug candidate is a consortia of … WebJul 5, 2015 · A healthy vagina is characterized by hydrogen peroxide and acid-producing lactobacilli, which are crucial to maintain the physiological vaginal ecosystem and their depletion speeds up bacterial... military time 1:00 am
2-Fluorodeoxyglucose on Breast Cancer - Clinical Trials Registry
WebDec 3, 2024 · LABthera-001 Infectious Disease 28 Oct 2024 Expected Trial Completions Phase II Trial Completion Expected on 26-Oct-2024 Research Mentor Co ltd LABthera-001 WebThis is a phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled, dose escalation, clinical trial enrolling 24 healthy participants. The main subject is to … WebAvoin etiketti, turvallisuustutkimus lisämunuaisen vaimennuksen mahdollisuuden arvioimiseksi Hoito DSXS: llä (Taro Pharmaceuticals U.S.A., Inc.) ... Kliinisten ... new york times monarchy